Close Menu
Finfold Times
  • Business
    • Finance
    • Fintech
    • Real Estate
    • Healthcare
  • Markets
    • Stocks
    • Cryptocurrency
    • Bonds
    • Funds
    • ETFs
  • Banking
  • Credit Cards
  • Mortgages
  • Investing
    • Invest in you
    • Personal Finance
    • Retirement
  • Loans
  • Insurance
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram LinkedIn
Finfold Times
Subscribe
  • Business
    • Finance
    • Fintech
    • Real Estate
    • Healthcare
  • Markets
    • Stocks
    • Cryptocurrency
    • Bonds
    • Funds
    • ETFs
  • Banking
  • Credit Cards
  • Mortgages
  • Investing
    • Invest in you
    • Personal Finance
    • Retirement
  • Loans
  • Insurance
Finfold Times
Subscribe
Home » Elon Musk’s Neuralink Under Investigation Over Illegal Transportation
Healthcare News

Elon Musk’s Neuralink Under Investigation Over Illegal Transportation

EditorEditorFebruary 14, 20232 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

The Physicians Committee for Responsible Medicine accused Neuralink Corp of improper handling and shipment of potentially hazardous materials. As a result, the US Transportation Department decided to initiate an investigation. Elon Musk’s brain implant firm is the target of the investigation.

The Physicians Committee for Responsible Medicine made an allegation. They claim that in 2019, Neuralink transported devices without following the proper procedure. Sickened primates may have contaminated the devices. The claims are based on emails obtained through a public records request. The emails show communication between Neuralink staff and employees at the University of California, Davis. Neuralink had contracted for primate research at the University of California, Davis, at the time.

The Pipelines and Hazardous Materials Safety Administration made a statement. They are part of the Transportation Department. The Administration stated that they are investigating Neuralink. The purpose of the investigation is to ensure compliance with federal regulations. They aim to protect the public and workers from potentially dangerous pathogens.

The Physicians Committee for Responsible Medicine, an animal welfare group, accused Neuralink of engaging in “sloppy and unsafe” practices in a letter to Secretary of Transportation Pete Buttigieg. The group claims that Neuralink may have transported a device from a monkey brain killed in March 2019 improperly, increasing the risk of transmitting a deadly herpes virus. Additionally, the group alleges that in April 2019, the University’s Primate Centre discovered three devices used in monkey brains back at the centre in an open box with no secondary container, violating regulations.

The Physicians Committee for Responsible Medicine obtained emails that cited a Primate Centre employee expressing concern for human safety and warning,

“Exposure to contaminated explanted hardware is a big deal and we are worried about human safety.”

Health and Safety USA
Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
Previous ArticleExperts Debate Over the Future of Social Security’s Retirement Age
Next Article Wells Fargo Warns ‘Fed is not your friend’ Ahead of Inflation Report
Editor
  • Website

Related Posts

Finance News

Why the Fed May Need to Cut Interest Rates Sooner

News Personal Finance

Grocery Costs Have Risen Since the Pandemic Began, and Consumers Feel the Strain

News Real Estate

Inflation and Limited Housing Supply Leave Homebuyers Distressed

Mortgages News

Mortgage Rates Hit the Lowest Level Since March, But Consumers Remain Unimpressed

DON’T FALL BEHIND

Stay current with our daily newsletter to get the latest industry news.


    FinanceFintechReal EstateHealthcareStocksCryptocurrencyETFsFundsBondsInvest in youRetirementPersonal FinanceMortgagesLoansCredit CardsBankingInsurance

    Disclaimer || Advertising Disclosure

    We are not financial advisers. The content on this site is for informational and educational purposes only and should not be construed as professional financial advice. Please consult a licensed financial or tax advisor before making any decisions based on the information you see here.

    We may be compensated through 3rd party advertisers, but our reviews, comparisons, and articles are based on objective measures and analysis.

    Markets
    • Stocks
    • Bonds
    • Cryptocurrency
    • ETFs
    • Funds
    Company
    • About
    • Disclaimer
    • Privacy Policy
    • Terms of Service
    • Cookie Policy
    • Advertising Disclosure
    • Contact Us
    Copyright © 2025 Finfold Times
    • Home
    • Business
    • Investing
    • Markets

    Type above and press Enter to search. Press Esc to cancel.